A Pharmacokinetic Study of Intravitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Diabetic Macular Edema
Latest Information Update: 04 May 2022
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic macular oedema
- Focus Pharmacokinetics
- Acronyms DRAW-2
- 21 Apr 2022 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 21 Oct 2020 New trial record